Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic CancerBenzinga • 09/14/21
Roche signs definitive share purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseasesGlobeNewsWire • 09/09/21
Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene TherapyBenzinga • 09/07/21
Roche to present data from industry leading portfolio at ESMO 2021 showing significant progress in early stage and uncommon cancersGlobeNewsWire • 09/07/21
Genentech to Present Data From Industry-Leading Portfolio at ESMO 2021 Showing Significant Progress in Early Stage and Uncommon CancersBusiness Wire • 09/07/21
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's DiseasePRNewsWire • 09/07/21
Else Nutrition expands its Plant-Based Complete Nutrition for Toddlers into Roche Bros. locations this SeptemberProactive Investors • 09/01/21
Roche Partners with the Kolisi Foundation, One By One Target Covid Campaign and Transnet to Launch Free COVID-19 Children's BookBusiness Wire • 08/30/21
Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancerGlobeNewsWire • 08/27/21
Genentech Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metastatic Triple-Negative Breast CancerBusiness Wire • 08/27/21
Seattle biotech firm Shape Therapeutics inks gene therapy deal with Roche worth up to $3BGeekWire • 08/24/21